𝗪𝗲𝗲𝗸𝗹𝘆 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 #11 📢

Patient Centricity and Pharmaceutical Companies: Is it Feasible?

In recent years, regulatory bodies have increasingly sought patient input, steering healthcare towards patient-centric models. This shift has challenged the pharmaceutical industry to redefine its role 🔄.

Back in 2017, industry leaders convened to address pivotal questions:

Industry Engagement: Why should the pharmaceutical sector embrace patient-centricity? 🎯
Becoming Patient-Centric: How can companies embody patient-centric principles? 💊
Defining Patient-Centricity: What characterizes a patient-centric organization? 🏥

Traditionally, Pharma focused on disease treatment. Yet, evolving healthcare demands emphasize initiatives that directly benefit patients and caregivers. True patient centricity demands a cultural shift within the industry. Examples include integrating patient-reported outcomes in clinical trials, enhancing treatment decision support, and capturing patient preferences. 💡

Looking ahead, realizing patient-centric goals hinges on collaborative efforts among stakeholders. The industry must champion these initiatives.

📚 Reference:
du Plessis et al., Patient Centricity and Pharmaceutical Companies: Is It Feasible? Ther Innov Regul Sci. 2017 Jul;51(4):460-467.